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Abstract 
Background: Caesarean section (CS) rates are increasing worldwide; rates in the private sector in South Africa are reported to be particularly high. 
To the best of our knowledge there has been no recent audit of Caesarean sections performed by the private health sector in KwaZulu-Natal. The aim 
of this study was to carry out an audit of CS in a private practice.
Methods: An audit of the patient records over a period of one year was done. No personal identifiers were noted or reported on. All relevant clinical 
data were pooled and used to analyse the clinical information.
Results: There were 364 deliveries in the study period and 209 of these were CS, giving a rate of 60.4%. Most of the caesarean sections were carried 
out because of a previous CS; maternal request and HIV status also contributed to the high rate.
Conclusion: The high CS rate in private practice is probably a window to the increased rates of Caesarean section being performed worldwide. 
This high rate is in keeping with trends in countries such as South America, and is considerably higher than the ideal rate of 10 to 15% in low-risk 
obstetric populations suggested by the WHO.
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Introduction
Caesarean section (CS) is a relatively common procedure in obstetric 
practice. However, CS rates vary worldwide, ranging from approximately 
10% in Sweden to about 80% in private-sector hospitals in Brazil.1,2 
Rates of approximately 30% are reported from regional and tertiary 
public hospitals in the Durban Metropolitan area (Department Statistics, 
KEH, 2007). These high rates are probably due to large proportions of 
high-risk patients attending tertiary and regional public hospitals in 
South Africa. Lower rates of CS would be expected in the private health 
sector, which is generally attended by people from the middle and high 
socio-economic population groups. 
Caesarean section rates have been reported to be high in some private 
hospitals in South Africa.3 More recently, Tshibangu et al. (2002) did 
a retrospective clinical survey comparing CS deliveries in the private 
sector with those in teaching and public hospitals in Gauteng, South 
Africa.4 These authors found, on average, a CS rate of 57% (11,572 CS in 
20 151 deliveries) at six private hospitals over a three-year study period 
compared to a CS rate of 28% and 19% in one teaching hospital and 
20 public hospitals respectively. The high CS rate in the private sector is 
of concern, particularly as the study was done between 1998 and 2000 
and the rates showed a steady increase from 1998 to 2000.
Current available data from well-resourced countries suggest that 
morbidity and mortality for both mother and baby arising from CS are 
higher when compared with vaginal delivery.5 Since these reports, 
CS rates are thought to have increased further due to maternal requests 
for planned CS and CS for HIV pregnant women. The present audit was 
therefore done to establish whether there is a further increase in CS 
rates in the private health sector in South Africa.
Methods
Institutional ethical approval and permission from a specialist private 
practice to audit the bed letters/notes of all their patients who had a 
CS over a period of one year (2004) was obtained. The practice was 
located in central Durban and all Caesarean sections were done at five 
private hospitals in this area. The majority of the population attending 
this private practice were on a medical aid scheme and belonged to the 
middle and high socio-economic groups. 
Demographic and clinical data, indications for CS and complications were 
recorded on a structured data form. No personal patient information was 
obtained or recorded. In addition, no personal identifiers were included 
in the data sheets. Only pooled data are presented. Gestational age was 
expressed in weeks and was based on an ultrasound performed before 
the twentieth week of gestation.
Caesarean sections for cephalo-pelvic disproportion (CPD) were 
performed on both an emergency and elective basis. The policy of this 
particular private practice was that CPD was highly likely in a patient 
with a high presenting part, an unfavourable cervix (i.e. low Bishop’s 
score) and/or a clinically big baby.
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CD4 counts and viral loads were performed on all HIV-infected patients, 
and they were referred to specialist physicians for the commencement of 
treatment with antiretroviral (ARV) drugs. These patients were delivered 
by elective CS and their babies were referred to neonatalogists for early 
HIV testing and appropriate follow up. 
Vaginal birth after CS and external cephalic version (ECV) at 37 weeks 
were offered following the provision of appropriate information and 
counselling to patients with previous CS and breech presentations 
respectively. Similarly, patients with twin pregnancies were given the 
option of deciding on the mode of delivery. Caesarean section was also 
performed on request in this practice, following information sharing and 
counselling.
It was the policy of this practice to use oxytocin for the augmentation of 
labour – very sparingly and judiciously in the presence of poor progress 
due to concerns of uterine hyper-stimulation and possible fetal distress.
Definitions
The Caesarean sections performed were divided into three groups on 
the basis of the following definitions, which are endorsed by the Royal 
College of Obstetricians and Gynaecologists: elective – at a time to suit the 
patient and the maternity team (obstetricians, anaesthetist, neonatologist 
and the nursing team); urgent – maternal or fetal compromise that is not 
immediately life-threatening; emergency – immediate threat to life of 
woman or fetus.  
Statistics
Descriptive statistics were utilised and all results are presented as 
frequencies, means and percentages.
Results 
There were a total of 346 deliveries during the one-year study period. 
Of these, 137 were vaginal deliveries and 209 were CS, giving a CS rate 
of 60.4%.
As reflected in Table I, there were no major differences between elective 
and emergency CS with regard to maternal age, parity and gestational 
age. However, the mean gestational age at delivery for the urgent CS was 
earlier when compared to the other two CS groups.
Laboratory data 
The mean haemoglobin (Hb) level in all three groups was similar; the 
mean Hb was 11.8, 12.0 and 12.1 g/dl in the elective, emergency and 
urgent CS groups respectively, and the range varied between 11.8 and 
12.1 g/dl. There were 10 patients who were HIV positive; eight had 
elective CS, one had an urgent CS, and the other had an emergency CS.
Indications for Caesarean section (Tables II to IV)
Of the 209 CS performed, 109 were elective, 18 urgent and 82 emergency. 
The majority of elective CS were done for previous CS (51 for previous CS 
x 1 and 13 for previous CS x 2). 
Two sets of twins were delivered by elective CS because, in both cases, 
the leading twin was breech, and five elective CS were done for breech 
presentations. The remainder of the elective CS were performed for 
standard obstetric indications, with the exception of two groups of 
patients. The first group consisted of nine patients in whom CS was 
performed on request. This group was analysed separately. The second 
group consisted of eight patients who had CS performed because of their 
positive HIV status. Eight patients had elective CS for CPD.
Caesarean section on request 
Nine patients requested CS. The mean age of these patients was 
29 years, at a mean gestation of 38 weeks and a mean parity of one. 
When compared to elective CS for other indications, the mean age and 
gestational age were similar. With regard to the professions of those 
who requested CS, three were professionals (all teachers). Five were 
primigravidae, three were parity 1 and one was parity 2. The reasons for 
Table I: Demographic data 
Number of NVDs 137
Number of CS 209
Total number of deliveries 346





Urgent CS Mean 
(range)
Maternal age – years 31 (20–45) 30 (19–43) 28 (24–36)
Parity 1 (0–5) 1 (0–3) 1 (0–3)
Gestational age – weeks 38 (28–40) 38 (27–41) 36 (30–41)
NVD – normal vaginal delivery  CS = Caesarean section
Table II: Indications for elective Caesarean sections
Indication Frequency Per cent  
Caesarean section on request 9 8.3
*Previous caesarean section x 1 51 46.8       
Previous caesarean section x 2 or more 13 11.9       
Bad obstetric history 1 0.9       
Placenta praevia 2 1.8       
Malpresentation (BX) 5 4.6       
Leading twin breech 2 1.8       
Elderly primigravida 1 0.9       
Medical condition 3 2.8       
Infertility 4 3.7       
CPD 8 7.3      
Previous myomectomy 1 0.9      
Multifibroid uterus 1 0.9      
HIV 8 7.3     
TOTAL 109 100.00   
* 41 of the 51 patients with previous CS x 1 were offered VBAC; all declined.
Table III: Indications for urgent Caesarean sections
Urgent Frequency Percentage  
Gestational hypertension / pre-eclampsia + IUGR 6 33.3         
Gestational hypertension / pre-eclampsia / no IUGR 6 33.3         
Idiopathic IUGR 4 22.2         
Twin-to-twin transfusion syndrome 1 5.6          
Postdates + reduced liquor 1 5.6          
Total 18 100.00
IUGR – intrauterine growth retardation
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requesting CS were only documented for two of the nine patients. One 
patient was a primigravida with a fear of vaginal delivery and another 
(parity 1) did not want to risk undergoing a repeat episiotomy. 
Neonatal outcome 
There was one early neonatal death (ENND) and one infant death. The first 
patient was a 26-year-old primigravida who was delivered by emergency 
CS at 35 weeks of gestation because of decelerations on electronic fetal 
heart rate monitoring by cardiotocograph (CTG). The patient was not in 
labour, but was also known to have intra-uterine growth restriction (IUGR) 
with reduced liquor and absent end diastolic flow (AEDF). A baby with 
poor Apgar scores and weighing 1.9 kg was delivered. The baby was 
diagnosed with Down’s syndrome following delivery and was ventilated, 
but died after one week because of hypoplastic lungs. 
The second patient had an emergency CS for abruptio placenta grade 2 at 
27 weeks’ gestational age. A baby weighing 1 kg was delivered and was 
ventilated for six days. The baby died on day 35 due to septicaemia. 
Maternal morbidity 
One patient had wound infection; she was a gestational diabetic and had 
undergone an elective CS for gestational diabetes. 
There was one case of secondary post partum haemorrhage (PPH), which 
occurred 48 hours after elective CS for previous CS x 1, having delivered 
a 3.3 kg baby. The bleeding stopped following the administration of an 
oxytocic infusion. 
Discussion
There are very few studies that provide comparative figures for CS 
rates in the private and public health sectors in South Africa. Price and 
Broomberg conducted a retrospective analysis of CS rates among white 
nulligravida aged 20 to 35 years.7 Data were collected from the records 
of 637 patients who delivered in a tertiary state hospital and 620 patients 
belonging to three medical aid schemes, most of whom delivered under 
the care of private practitioners. A CS rate of 19.5% was found in the 
tertiary health institution, while the CS rate in the medical aid scheme 
patients was 28.7%. The authors therefore concluded that patients 
delivering in the private “fee-for-service” sector were 50% more likely to 
have a CS than those delivering in the public sector (28.7% vs 19.5%).
This information is similar to that in reports from the rest of the world, 
which show that CS rates in the private sector are much higher than 
those in public hospitals.5
The CS rate of 28.7% among patients belonging to medical aid schemes 
reported by Price and Bloomberg is much lower than the CS rate of 
60.4% found in the present audit. This high figure probably reflects the 
trend of rising CS rates seen in recent years, as the aforementioned 
study was conducted 15 years before the present audit, but may also be 
higher due to factors that were not as significant 15 years ago as they 
are now, viz. maternal request for CS, the HIV status of the patient and 
the fear of litigation due to an increasing number of malpractice cases 
in South Africa.
Indications for caesarean section
The main overall indications for CS in the present audit were previous 
CS (51/209; 24.4%) emergency CS for CPD (17/209; 8.13%) and elective 
CS for previous CS x 2 (13/209, 6.2%). These findings are not dissimilar to 
those reported by Tshibangu et al.4 It ought to be noted that these authors 
were only able to obtain data on indications for CS done at one of the six 
private hospitals, in which 74.6 % of the CS were performed electively 
and the most common indication for elective delivery was a previous 
CS (39.2%). This probably indicates that the main indications for CS in 
the private sector are similar throughout South Africa. Documentation 
of indications for CS appears to be a problem in the private health 
sector, however, since the present audit found that although the policy 
of the audited private practice was to offer vaginal birth after Caesarean 
section (VBAC) to all patients who had had a previous CS, there were 
no records of this in the patients’ charts. It seems contradictory that 
although obstetricians fear litigation and that this fear might be one of the 
reasons for rising CS rates, there appears to be a lack of documentation 
of procedures and processes in the private sector.
In the audit by Tshibangu et al, the patients’ choices contributed 5.4% 
of the indications for CS, while in the present audit maternal request for 
CS constituted 8.7% of the elective CS, a figure 1.5 times higher.4 This 
might reflect the rising trend in recent years for women to request CS. 
The figure in the present audit is more in keeping with the UK figure of 
7%, and may also be indicative of the socio-economic groups (middle 
and high) which attended the audited private practice. 
In the present audit, eight out of 10 HIV-positive patients had elective 
CS, while the other two had emergency CS because of their positive 
status. This group comprised 7.3% of all elective CS and 3.8% of the 
total number of CS done, and is much higher than the figures reported 
by Tshibangu et al.4 The probable reasons for this difference may be 
Table IV: Indications for emergency Caesarean section
Indication Frequency Percentage
Failure to progress 3 3.7                
Cephalopelvic disproportion 18 22.0             
Combination cephalopelvic disproportion + fetal 
distress 3 3.7             
Failed induction of labour 6 7.3             
Breech presentation in labour 1 1.2             
Abruptio placentae G2 9 11.0             
Failed VBAC 1 1.2            
Twins, PROM, leading twin breech 1 1.2            
Previous caesarean section x 3 + imminent eclampsia 1 1.2           
Imminent eclampsia + unfavourable cervix 1 1.2           
Previous caesarean section x 1 + PROM 5 6.1           
PROM + unfavourable cervix 4 4.9           
Previous caesarean section x 1 in labour  
(declining VBAC) 3 3.7           
Twin pregnancy, advanced maternal age 1 1.2           
Delayed 2nd stage 2 2.4          
Antepartum haemorrhage of unknown origin 4 4.9          
CTG abnormality 9 11.0          
Meconium 5 6.1          
Meconium + CTG abnormality 5 6.1         
Total 82 100.00
CTG = cardiotocograph; VBAC = vaginal birth after caesarean section;  
PROM = prelabour rupture of membranes
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the variance in the time periods in which the studies were done and 
the different population groups studied. It is also possible that these 
figures are lower than what one would expect, given that KwaZulu-Natal 
is known to have the highest prevalence rates of HIV in South Africa. 
However, HIV is known to affect mainly the poor socio-economic groups 
and is a disease of poverty. 
There are robust data available to show that elective CS is of value in 
decreasing the mother-to-child transmission (MTCT) of HIV.8 However, 
its value in decreasing MTCT in patients with undetectable viral loads is 
debatable. There are some authors who believe that viral loads in blood 
do not correlate with the levels in genital tract secretions in the vagina, 
and therefore the dangers of vaginal delivery remain. Further randomised 
studies are required to settle this matter before recommendations can 
be made in respect of the mode of delivery in women with undetectable 
viral loads.8 
In the audit by Tshibangu et al., 21.2% of the elective CS were done as 
the doctor’s choice, the second most common reason given for elective 
CS.4 The authors described this as a “new and non-classic indication” 
and provide several reasons, including convenience, financial incentive, 
absence of skilled midwives in labour wards and refusal of doctors to 
attend deliveries over weekends and/or on holidays. These indications 
are very contentious and are so vague that they may be difficult to 
confirm in any audit, particularly given the lack of proper records. Similar 
contentious indications include tubal ligation and medical conditions 
such as diabetes. These are not standard obstetric indications for CS. 
The present audit did not include tubal ligation as an indication for 
CS, but included CPD as an indication for elective CS. This is a questionable 
indication, although this private specialist practice based its diagnosis on 
clinical grounds (high head, big baby and unfavourable cervix) in the 
antenatal period. Most clinicians would argue that the diagnosis of CPD 
can only be made in labour. However, in a study done by O’Leary et al 
that evaluated trends in the mode of delivery in Western Australia from 
1984 to 2003, a diagnosis of CPD was associated with a 48% chance 
of elective CS and a 46% chance of emergency CS.9 Information such 
as this may influence doctors in private practice to resort to CS when in 
fear of litigation.
A national audit conducted in the UK has shown that maternal request 
(7%) is now the fifth most common reason given for performing a CS, 
after fetal compromise (22%), “failure to progress” (20%), repeat CS 
(14%), and breech presentation (11%).10 In the present audit, a similar 
rate of 8.26% (9/109) was found for CS on request, and this was the 
third commonest indication for elective CS, after previous CS x 1 at 
46.8% (51/109) and previous CS x 2 at 11.9% (13/109). Fetal distress 
was significantly lower, at a rate of 9.1%, while repeat CS was more 
than three times the rate in the UK, constituting 46.8% (51/109) of the 
elective CS.
The difference in rates for fetal distress between South Africa and the 
UK probably lies in the diagnosis. It is well known that CTG abnormalities 
lead to an over-diagnosis of fetal distress. The most accurate parameter 
of intrauterine fetal hypoxia is a “PH sample” of the fetal scalp blood. 
This practice has fallen away in South Africa, mainly due to the high HIV 
rates, a lack of appropriate equipment in public sector hospitals and a 
lack of the necessary skills to obtain fetal scalp blood samples, both 
in the private and public sectors. In the absence of such methods, the 
diagnosis of fetal distress should take into account other factors, such 
as the type of CTG abnormalities, the presence of meconium, whether 
there is IUGR, the ability to perform intense fetal monitoring and the 
background obstetric history of the patient. 
Similarly, failure to progress may be targeted as an indication for 
conservative measures prior to a decision for CS. Proper and skilled 
pelvic examination to exclude CPD and the subsequent judicious use of 
oxytocin to augment labour may reduce the need for CS without affecting 
fetal outcome. 
Doctors in private practice may be reluctant to resort to conservative 
measures, fearing litigation and being cautious in respect of the lack of 
intense fetal and maternal monitoring when oxytocin is used, and fearing 
uterine hyperstimulation and subsequent fetal distress. Doctors may also 
be wary of the lack of nursing staff to attend to high-risk pregnancies 
in respect of maintaining continuous fetal heart monitoring, the inability 
of nurses to interpret subtle cardiotocographic changes and their own 
ability to attend to an unexpected emergency, particularly if they are in 
a single practice. The abovementioned factors probably also apply when 
VBAC is considered. 
Previous CS is the single most common indication for elective CS 
worldwide, and offering VBAC is one way of reducing high CS rates. 
However, rates of VBAC are declining in the USA, from 28.3% in 1996 
to 12.7% in 2002. This is in contrast to the UK, were the rates of VBAC 
remain fairly high at 33%.11 While the risks for maternal and perinatal 
morbidity and mortality are reported to be relatively low,12 there are 
contrasting views. McMahon et al found higher rates of maternal and 
fetal morbidity in those choosing VBAC in comparison to those who opted 
for elective CS.13 This publication in a major journal is probably one of 
the reasons for the declining VBAC rate in the USA. Despite this, the 
National Institute of International Excellence (NICE) in the UK provides 
guidelines in which information is shared with all women who have 
had a previous CS to help them make an informed choice regarding the 
mode of delivery.14 Thus, sufficient time should be taken by all doctors 
to provide efficient counselling. In the present audit, only one record was 
noted of a CS done for failed VBAC. 
Similar to offering VBAC, external cephalic version (ECV) should be 
offered to all women with breech presentations at 37 weeks’ gestation. 
Five patients in the present audit had elective CS. The Term Breech Trial 
has certainly had an impact on obstetric practice in respect to elective 
CS for breech presentations.15 The policy of the audited practice was to 
offer ECV to women with breech presentations at 37 weeks as a way 
to decrease CS rates. However, no documentation could be found on 
their being offered ECV, or on the success or failure of the procedure. 
It would appear that doctors in specialist practice may offer ECV but 
are reluctant to do the procedure, as it is time-consuming, or that they 
may lack the skills required to perform an ECV. Like most things, if one 
does not develop the skill during training one is hesitant to carry out the 
procedure in private practice. The NICE guidelines suggest ECV as an 
intervention to reduce high CS rates.14
High rates of caesarean section 
The high rates of CS found in the present audit are probably a reflection 
of the trend in South Africa. Bateman, a commentator for the South 
African Medical Journal, reported a CS rate of 65% in the private sector 
in South Africa in 2004 and pointed out that this was almost double the 
percentage in the UK and the USA and therefore a real cause for concern. 
He also reported that the equivalent South African public sector figure 
was estimated to be between 10 and 20%, which was only marginally 
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higher than that in several leading first-world public health systems.16 
A major South African medical aid scheme was reported to have a 
CS percentage of 63% of total deliveries.16 This is in keeping with 
our findings.
The question has been raised whether there is an ideal CS rate. The WHO 
adopted a figure of 15% world wide, based on the CS rates in countries 
with the lowest perinatal mortality and morbidity. It is likely, however, that 
CS rates would vary considerably depending on a multitude of factors, 
such as pre-eclampsia, intrauterine growth restriction, the prevalence 
of CPD and medical complications in pregnancy, and cultural attitudes 
towards CS. Althabe et al recently investigated maternal and neonatal 
morbidity and mortality in 119 countries and found no association 
between CS rates and maternal and neonatal morbidity in middle- and 
high-income countries.17 These authors also suggest that making CS 
section available for high-risk pregnancies in low-income countries 
could contribute to improved maternal and neonatal outcomes, whereas 
a system of care to keep CS rates below 10% would be unlikely to cover 
their needs. More recently, Villar et al assessed the risks and benefits 
associated with CS compared with vaginal delivery within the cohort 
of the 2005 WHO global survey on maternal and perinatal health.18 
They concluded that CS reduces the overall maternal and neonatal risk 
in breech deliveries and the risk of intrapartum fetal death in cephalic 
presentations, but increases the risk of severe maternal and neonatal 
morbidity and mortality in cephalic presentations. 
One of the difficulties when trying to reduce CS rates could be the low 
perinatal and maternal complication rates associated with planned CS. 
This audit found that there was only one early neonatal death and one 
infant death, both of which could be regarded as non-preventable. More 
importantly, there was no perinatal morbidity. The likely reason for this 
is that most cases were at term. The maternal complication rate was 
also low, with only a case of wound infection and a secondary PPH. 
This is in contrast to a public hospital in Durban, where the maternal 
complications associated with CS were at 14%, which is indicative of the 
high-risk cases seen in the public sector.19
The present audit confirmed that CS rates were high in a private practice 
in Durban. However, the audit did have a few shortcomings in that it 
was unable to determine the actual number of VBACs or ECVs that were 
successful. There was only one record of a failed VBAC. An audit of all 
patient records (antenatal and labour, rather than just the patients who 
had CS) may have provided a more complete picture.
Conclusion
While it is undeniable that planned CS at maternal request and in the 
case of breech delivery and HIV have contributed to rising CS rates in 
this private practice, the major contributor was elective CS for patients 
with a previous CS. This suggests that, in order to curb rising CS rates, 
careful thought should be given to the outcome of future pregnancies 
when making the decision to perform a primary Caesarean section. 
Auditing of CS rates in the private sector may provide specialists with 
information that will influence the way they practice. Setting aside more 
time for counselling patients on VBAC and ECV may help bring down high 
Caesarean section rates in the private health sector in South Africa.
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